Article

Three ways that digital-first care can improve patient safety

October 5, 2022
Article

Three ways that digital-first care can improve patient safety

October 5, 2022

Peter Kirpalani-Collins

Global Clinical Director of Patient Safety & Quality

This is some text inside of a div block.
mins read
Speaker shot.

Speaker shot.

Speaker shot.

Safer patient monitoring through digital care

Over the years, medical culture has shifted its mindset to focus more closely on patient safety, recognizing the need for better collaboration and communication. With digital-first care, patient safety in the healthcare system is continuing on a path toward zero harm.

Increasing medication adherence

During the COVID-19 pandemic the public, as well as symptomatic patients, were under quarantine orders preventing many patients from seeking care. A study on remote-patient monitoring showed that digital-first care provided a safe and effective option for patients with COVID-19.

In the study, patients who tested positive for COVID-19 were supplied with pulse oximeters and access to a mobile application for remote monitoring and self-reporting of symptoms. A nursing team was also available for in-home visits if needed. This setup allowed clinicians to safely monitor at-home patients for signs of deterioration before the situation became critical. Patients enrolled in the study were significantly older, with a median age of 51, putting them in a higher risk category for hospitalization from COVID-19.

“ An overwhelming 98.9% believed they were well monitored with this process, and the 94.5% of patients who had a fear of COVID-19 felt more reassured after using the app.”

Study results

The results of the study showed that remotely-monitored patients requiring admission were admitted to the hospital at a higher rate (14.81% vs 6.89%-7.22% for surrounding areas); they also had a lower rate of ICU admission and spent fewer days in the hospital (6 days vs 10 days). Importantly, mortality rates were also 3-4 times lower for the patients who were remotely monitored compared with those in the general community.

Post-study questions

At the end of the study, patients were asked a series of questions about their experiences. An overwhelming 98.9% believed they were well monitored with this process, and the 94.5% of patients who had a fear of COVID-19 felt more reassured after using the app.

DeTAP Study

As previously reported, the pandemic had a significant and detrimental impact on clinical trials, with over 300 trials disrupted. Digital-first care offers a new way forward with decentralized clinical trials. The first 100% decentralized trial, named DeTAP, demonstrated the utility and ease of this new trial design. DeTAP was a six-month, single-arm, virtual study that recruited 100 patients with atrial fibrillation.All participants were >55 years old and were taking oral anticoagulation medication. Enrollment and participation all took place on an app, through which patients were able to provide consent for the study and relay data from remote blood pressure and electrocardiogram sensors. The app collected the data and enabled reminders, surveys, educational content, and video calls.

Progress of the trial

The trial saw rapid recruitment, with 94% enrollment reached in just 12 days. The primary endpoint, a televisit, was completed by 91% of the study participants. Additionally, patients with lower medication adherence at baseline increased their adherence over the course of the study.

At the end of the study, 86% of participants indicated that they would be willing to enroll in a longer 12-18 month trial.

With better trial enrollment, researchers can collect data on a more diverse population, leading to better health outcomes with medications and evidence-based practices.

Two trials, one conclusion

While digital-first care is still in the early stages, these two trials demonstrate that it can and does improve patient safety. Clinicians and researchers have known that an engaged patient is a healthier patient. To make digital-first care work, we need to understand what patients want digital health to look like and how they want the platforms to work for them.

That is why at Huma we have iterated our platform countless times over the last decade, captured millions of different data points, and collected hundreds of hours of qualitative insights. All of this has helped us build a platform that is intuitive and fun to use.

User feedback

At the end of the COVID-19 remote-monitoring study, 92.8% of patients reported they found the app easy to use, and only 14.9% needed any help learning how to operate the app.

These important findings show that patients are willing to engage with digital-first health and that this approach towards treatment can have a positive impact on patients’ lives.

Interested in Huma? Let’s talk!

This field is required
Email must be formatted correctly
This field is required
This field is required
This field is required

Huma is committed to respecting your privacy, we’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes. You can unsubscribe at any time. Review our Privacy Policy for further information.

Keep up to date on our current work and research with the latest marketing updates from Huma, including monthly news, events and communications on products and services.

By clicking submit below, you consent to allow Huma to store and process the personal information submitted above to provide you the content requested.

One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.

This field is required
This field is required
This field is required
This field is required
Thank you for your request.
You will receive an email from us shortly containing the file. Please check your inbox (and promotions tab or spam folder, if necessary) for the email.
Oops! Something went wrong while submitting the form

Email must be formatted correctly
This field is required
This field is required
This field is required
This field is required
This field is required
Country/Region*
This field is required
I'm interested in

Huma is committed to respecting your privacy, and we’ll only use your personal details to provide information you have selected you’re interested in. Review our Privacy Policy for further information.

We’d love to send you our monthly newsletter about our latest work, research and events by email. We’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.

You’re in control. You can, of course, withdraw your consent at any time. Review our Privacy Policy for further information.

One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.

Making an impact

3000+

3000+ hospitals and clinics supported across Huma platforms to secure the most sustainable impact for patients1

×2

Our platform can almost double clinical capacity and reduce readmission rates by >30%3

27m+

Huma's digital-first health platforms support a network of 27m patients1

1m+

Over 1 million devices have been shipped in support of our projects and we know what it takes to deploy at scale1

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Selected as one of 'The Most Important Healthcare Design of 2021' by Fast Company5

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4

Sources:

Article

Three ways that digital-first care can improve patient safety

October 5, 2022
Article

Three ways that digital-first care can improve patient safety

October 5, 2022

Huma joins digital pioneers to advance health equity in care and research

Chief Executive Officer and Founder, Dan Vahdat, is returning to the annual World Economic Forum’s main conference where he will join a panel discussion devoted to improving care for non-communicable disease and tackling health equity. Accompanied by Chief Financial and Strategy Officer, Ingeborg Oie, Dan is looking forward to connecting with other attendees to explore how Huma’s digital health platform can make healthcare more equitable, and advances proactive, predictive care.

Huma joins digital pioneers to advance health equity in care and research

Date:Wednesday, January 18, 2023
Time:4:15 - 5:15 p.m. CET
Location:Ice Village, Eisbahnstrasse 5, Davos, Switzerland
Dan will join the Digital Health Action Alliance panel at Davos to discuss Turning the Tide in Non-Communicable Disease Care Through Digital Health and Community Connection. Huma has a long history of advancing the care of non-communicable diseases (NCDs) such as heart disease, cancer, diabetes and lung conditions. Huma’s innovative remote patient monitoring platform enables broad patient recruitment, reduces reliance on in-person clinic visits and increases health system efficiency.
*This session is open to registered Annual Meeting 2023 participants and Affiliate badge holders.

Huma is one of the first to sign the Zero Health Gaps Pledge

Huma is one of the first signatories to the Zero Health Gaps Pledge, the World Economic Forum’s Global Health Equity Network’s (GHEN) initiative. Huma supports GHEN’s ambition to build a future without disparities in health or wellbeing outcomes. Huma’s digital platform has been built on a deep clinical knowledge of complex patient needs and how people engage with technology and we are committed to ensuring our technology promotes health equity. We are proud to work with governments, hospital groups, universities, life science and technology companies to bring greater scale and impact and help all people live longer, fuller lives.

Huma at World Economic Forum

Global Innovators and Tech Pioneers
Dec 2022: Huma selected to join 100 innovative companies on a two-year journey as part of the World Economic Forum’s initiatives, activities and events, bringing their cutting-edge insight and fresh thinking to critical global discussions.
Learn more
Working Together, Restoring Trust
May 2022: With the aim to address economic, environmental, political, and social fault-lines exacerbated by the COVID-19 pandemic, Dan Vahdat speaks at WEF annual meeting about the importance of scientific collaboration.
Learn more
Accelerating innovation and breaking new ground
October 2022: Dan joined the WEF Biotech Future Forum 2022 to discuss how start-ups are breaking new ground in biotech and changing the way we interact with the world, but also how the sector can earn trust, scale successfully and spot the brightest innovations.
Learn more
Making connections at Davos
Jan 2019: Dan attended WEF as an unofficial attendee and spoke to CNBC about the importance of meeting in-person to make connections.
Learn more

Related Articles

See more
Article
AI is in our DNA
Explore how Huma has been developing AI to revolutionise healthcare, and request a meeting with us to find out more.
Learn more
Article
“It’s really gold dust” Why Huma is a big step forward for knee surgery
Discover how Huma is providing Smith+Nephew with real world evidence for robotic knee replacement surgery.
Learn more

Related Blogs

See more
Blog
How Huma is transforming Health
Tim Broke-Smith, Huma's Vice President, Global Pharma Partnerships, considers how cutting edge technology can transform healthcare.
Learn more
Blog
Diabetes goes digital
Explore this blog featuring the Q&A session with Edith Giemula to uncover the ways in which digital tools are revolutionising diabetes research.
Learn more

Related Ebooks

See more
Ebook
Welcome to next-generation digital-first care and research
Deliver more personalised digital-first care and research with the first disease agnostic enterprise platform to achieve EU MDR Class IIb certification1.
Learn more
Ebook
What does FDA 510(k) Class II mean for Huma and our partners
Deliver more personalised digital-first care and research with our enterprise platform which now has FDA 510 (K) Class II clearance for any physician-specified condition.
Learn more

Related White Papers

See more
White Paper
Navigating the DCT transition
Learn how remote trial technology is changing the clinical trial landscape and key considerations when including DCT components in your study protocols.
Learn more
Article

Three ways that digital-first care can improve patient safety

October 5, 2022
Media contact
A headshot of Karen Birmingham PhD
Karen Birmingham PhD
Head of PR & Communications
karen.birmingham@huma.com
Article

Three ways that digital-first care can improve patient safety

October 5, 2022
Media contact
A headshot of Karen Birmingham PhD
Karen Birmingham PhD
Head of PR & Communications
karen.birmingham@huma.com

Safer patient monitoring through digital care

Over the years, medical culture has shifted its mindset to focus more closely on patient safety, recognizing the need for better collaboration and communication. With digital-first care, patient safety in the healthcare system is continuing on a path toward zero harm.

Increasing medication adherence

During the COVID-19 pandemic the public, as well as symptomatic patients, were under quarantine orders preventing many patients from seeking care. A study on remote-patient monitoring showed that digital-first care provided a safe and effective option for patients with COVID-19.

In the study, patients who tested positive for COVID-19 were supplied with pulse oximeters and access to a mobile application for remote monitoring and self-reporting of symptoms. A nursing team was also available for in-home visits if needed. This setup allowed clinicians to safely monitor at-home patients for signs of deterioration before the situation became critical. Patients enrolled in the study were significantly older, with a median age of 51, putting them in a higher risk category for hospitalization from COVID-19.

asdasd

asda

asdsads

asda

asdsad

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor
Download
Share this
COMPANY

About Huma

Huma began its journey in 2011, when the company was founded in London. Since then, Huma has grown to become a global healthcare company, spanning across multiple geographies and operating across four continents.

Learn more